XM does not provide services to residents of the United States of America.

Dollar slips on profit taking but upbeat outlook remains

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>FOREX-Dollar slips on profit taking but upbeat outlook remains</title></head><body>

Adds analyst comment and market details, changes dateline, previously SINGAPORE/LONDON

By Saqib Iqbal Ahmed

NEW YORK, May 24 (Reuters) -The dollar slipped broadly on Friday as traders booked profits after recent gains but the U.S. currency remained well-placed for further advances, supported by strong U.S. economic data that has prompted markets to dial back expectations for interest rate cuts.

Data on Friday showed new orders for key U.S.-manufactured capital goods rebounded more than expected in April and shipments of these goods also increased, suggesting a pickup in business spending on equipment early in the second quarter.

This follows Thursday's data that showed U.S. business activity in May accelerated to the highest level in just over two years and manufacturers reported surging input prices.

Minutes from the Federal Reserve's last meeting published this week showed a lively debate among policymakers as to whether current rates were sufficiently restrictive to cool inflation.

The dollar was down 0.3% at 104.74 against a basket of currencies on Friday, after advancing in five of the last six trading sessions. The euro was up 0.3% at $1.08495.

"Investors are just now taking the opportunity to reflect back on the week and take some profits ... it's really purely a positioning play," said Boris Kovacevic, global market strategist at payments company Convera in Vienna.

While stronger-than-expected U.S. economic data has led traders to push out the timing of the first Fed rate cut to September, expectations for rate cuts by other central banks have also slipped. FEDWATCH

"For as much as expectations of easing from the Federal Reserve have cooled off over the last week, it's a similar story for central bankers around the world - ECB rate cut changes have also downshifted after lots of official commentary since Monday," said Helen Given, FX trader at Monex USA in Washington.

Despite Friday's retreat, the near-term outlook for the dollar was upbeat, analysts said.

"This theme of the U.S. exceptionalism is still playing out," Convera's Kovacevic said.

The dollar is up almost 1% this week on the Japanese yen to 156.98 JPY=EBS yen, even though Japanese government bond yields have climbed too, scaling decade highs and clearing 1% at the 10-year tenor JP10YTN=JBTC. JP/

Japan's core inflation slowed for a second straight month in April, meeting market expectations - and staying above the central bank's target - at 2.2%.

"It's having very little effect on the yen," said Martin Whetton, head of financial markets strategy at Westpac in Sydney. "The carry of holding dollars is far juicier," he said, while policymakers' rhetoric has also made traders nervous about inflation and the risk rate cuts would be distant or small.

The pound rose 0.3% to $1.27345 on Friday.

Data showed wet weather hit UK consumer spending far more than expected in April, but evidence of sticky inflation, and the surprise announcement this week of a July general election kept sterling near two-month highs.

China started a second day of war games around Taiwan. China's yuan held steady in the offshore market CNH=D3 around 7.262.

The New Zealand dollar NZD=D3 was up 0.3% at $0.61185, underpinned by a hawkish shift in outlook from the Reserve Bank of New Zealand.

Among cryptocurrencies, ether ETH= was down 1.2% at $3,707, a day after the U.S. Securities and Exchange Commission approved applications from Nasdaq, CBOE and NYSE to list exchange-traded funds (ETFs) tied to the price of ether, potentially paving the way for the products to begin trading later this year. For the week, ether is up 20%.

Reporting by Saqib Iqbal Ahmed in New York
Additional reporting by Amanda Cooper and Tom Westbrook in Singpoare
Editing by Shri Navaratnam, Chizu Nomiyama and Matthew Lewis


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.